Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert S Warren

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
The Journal of Surgical Research|July 6, 2010
Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary siteYu-cheng Wang, Gioia Iezza, Marlene B Zuraek, et al.
Journal of Surgical Oncology|April 16, 2020
A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumorsYosuke Kasai, Kelly Mahuron, Kenzo Hirose, et al.
Journal of Surgical Oncology|October 16, 2019
Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumorsYosuke Kasai, Kelly Mahuron, Kenzo Hirose, et al.
Endocrine-Related Cancer|January 6, 2010
The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestineYu-cheng Wang, Marlene B Zuraek, Yasuhiro Kosaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Imaging a functional tumorigenic biomarker in the transformed epitheliumAaron M LeBeau, Minhee Lee, Stephanie T Murphy, et al.
Journal for Immunotherapy of Cancer|March 28, 2017
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancerKristen M Hege, Emily K Bergsland, George A Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapyFrank A Sinicrope, Michelle R Mahoney, Thomas C Smyrk, et al.
Journal of Surgical Oncology|December 13, 2019
Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasisYosuke Kasai, Kenzo Hirose, Carlos U Corvera, et al.
Plos One|July 11, 2019
High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinomaDavid B Donner, Eric K Nakakura, Alan P Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)Nancy E Kemeny, Donna Niedzwiecki, Donna R Hollis, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
The Journal of Surgical Research|July 6, 2010
Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary siteYu-cheng Wang, Gioia Iezza, Marlene B Zuraek, et al.
Journal of Surgical Oncology|April 16, 2020
A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumorsYosuke Kasai, Kelly Mahuron, Kenzo Hirose, et al.
Journal of Surgical Oncology|October 16, 2019
Prognostic impact of a large mesenteric mass >2 cm in ileal neuroendocrine tumorsYosuke Kasai, Kelly Mahuron, Kenzo Hirose, et al.
Endocrine-Related Cancer|January 6, 2010
The ETS oncogene family transcription factor FEV identifies serotonin-producing cells in normal and neoplastic small intestineYu-cheng Wang, Marlene B Zuraek, Yasuhiro Kosaka, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2012
Imaging a functional tumorigenic biomarker in the transformed epitheliumAaron M LeBeau, Minhee Lee, Stephanie T Murphy, et al.
Journal for Immunotherapy of Cancer|March 28, 2017
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancerKristen M Hege, Emily K Bergsland, George A Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapyFrank A Sinicrope, Michelle R Mahoney, Thomas C Smyrk, et al.
Journal of Surgical Oncology|December 13, 2019
Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasisYosuke Kasai, Kenzo Hirose, Carlos U Corvera, et al.
Plos One|July 11, 2019
High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinomaDavid B Donner, Eric K Nakakura, Alan P Venook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)Nancy E Kemeny, Donna Niedzwiecki, Donna R Hollis, et al.
Pageof 6